Clinical Trial Update: Healthcare Utilization and Economic Burden of Cardiomyopathy in China

View source ↗

Summary

A clinical trial evaluating healthcare utilization and economic burden associated with cardiomyopathy in China, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Cardiomyopathies, Economic Burden | Status: ENROLLING_BY_INVITATION